Martin Olin
Born 1969, MSc, E*MBA (SIMI), Partner and Investment Director

Olin started his career in 1989 as an auditor with PriceWaterhouse, working with auditing and management consulting with the focus on medium to
large companies. In 1996, he joined Novo Nordisk A/S, Corporate Finance (Denmark), as a manager responsible for cost accounting and
management reporting for the enzyme business worldwide. During his time with Corporate Finance, he participated in the restructuring of the
production process, the implementation of new global IT solutions, activity-based costing and divestment activities.

From 1998 to 2000, Olin was Finance Director for Europe, the Middle East & Africa, based in Paris (France), and was responsible for finances, legal
and IT in the region. During his time in Paris, Olin implemented a new sales reporting system and was given responsibility for the central customer
service function and managed 45 people in more than 12 different countries.
Olin joined SLS Invest in April 2000 as Investment Manager and CFO and have transitioned into a full-time Investment Director.

Olin has broad-based international experience with more than a decade of board work experience and a network made up of strong financial and
legal skills and expertise.

Olin is board member of Light Sciences Oncology Inc., PreciSense A/S, NsGene A/S, Metacure Inc., Cellectricon AB, Gyros AB and Chempilots A/S.

Contact:
+45 3264 8185
Martin.olin@slsinvest.com